Optimizing Patient Outcomes with Adjunctive OTC Skincare​

Join Dr. Ted Lain, Chief Medical Officer at Sanova Dermatology, and Star Walsh, R&D Director at Neutrogena®, for an informative webinar on the latest science and role of adjunctive OTC skincare in optimizing patient outcomes. Explore Hydro Boost Technologies and the latest findings on pre/post-procedure care & complementary Rx support. Discover valuable insights from the science behind Neutrogena®.

Ted Lain, MD
Chief Medical Officer at Sanova Dermatology
Executive Director at Austin Institute for Clinical Research
Austin, Texas

Star Walsh
R&D Director at Neutrogena® Skin Health